A nutritional placebo-controlled study was performed in Wistar rats in order to investigate the effects of 5-weeks aronia juice consumption towards fatty acid (FA) composition of phospholipids in the plasma and liver, as well as plasma glucose (Glu) and cholesterol levels. The animals were divided into 3 groups of 8 animals each, and randomized to receive either the full polyphenol dose of Aronia melanocarpa juice (AMJ), 4 times less polyphenol dose (¼-AMJ) or polyphenol-lacking placebo beverage (PLB). Each group of 8 male adult Wistar rats received the liquid ad libitum. AMJ decreased the levels of low-density lipoprotein (LDL) (P < 0.05) vs. PLB. AMJ increased dihomo-γ-linoleic acid (DGLA, 20:3n-6) (P < 0.05) and decreased arachidonic acid content (AA, 20:4n-6) (P < 0.05) vs. PLB in liver phospholipids. AMJ signifi cantly increased monounsaturated fatty acids (MUFA) levels both in the liver (P < 0.05) and plasma (P < 0.05). Both aronia juice doses elevated the levels of benefi cial n-3 polyunsaturated fatty acids (PUFA) in the plasma and liver. There was a dose-dependent, signifi cant increase (P < 0.001) in cis-vaccenic acid (VA, in phospholipids in the plasma and liver. Our results indicate favorable effects of aronia juice intake on lipid parameters in Wistar rats. These fi ndings suggest the potential of aronia dietary intake in cardiometabolic diseases primary prevention strategies in the human population.
INTRODUCTION
Aronia melanocarpa (AM), a berry fruit, has been scientifi cally investigated for a wide array of health-promoting characteristics. The benefi cial properties of AM on health are attributed to the high content of non-nutritional phytochemicals i.e. polyphenols [1, 2] , both fl avonoid and non-fl avonoid subclasses. Benefi cial effects of polyphenol intake have been studied thoroughly [3, 4] , mostly in the context of chronic disease prevention.
Fatty acids (FA) are stored at different rates in different tissues [5, 6] , thus potentially infl uencing particular tissue metabolism. The phospholipid FA composition and cholesterol content are basic determinants of the physical properties of biomembranes. They have been shown to infl uence a wide variety of membrane dependent functions such as membrane transport, enzyme activity and receptor function [7] . The FA profi le in tissues partly refl ects not only the dietary fat intake, but also the effi ciency of FA metabolism in the body [8] . The liver has an important role in the synthesis and metabolism of phospholipids. Liver phospholipids are a building structure of the hepatocyte membrane, they take part both in metabolic activities and repairing after metabolic disturbances [9] .
Recently, rat animal models have been exploited for the investigation of the protective effects of consumption of AM polyphenols towards the accumulation of xenobiotics in soft animal tissues [10] . However, a limited number of available studies deals with the biological effects of AM consumption regarding cardio metabolic biomarkers in rats. Existing preclinical data indicate anti-oxidative [11, 12] , hypotensive [13] , lipidlowering [1, 14] and glucose-regulating [15] effects in rats treated with AMJ. There is a limited number of studies dealing with the polyphenol-rich diet impact on lipid and FA status in rodent models [16, 17] . So far, none of the studies has investigated the biological effect of polyphenols contained in AMJ towards FA tissue content in rats. In addition, none of the available animal studies investigated the dose-response biological effects of aronia juice towards the status of phospholipids FA content in tissues.
We challenged the benefi cial effects of aronia juice long-term consumption in rats on phospholipid plasma and liver FA composition, as well as on some biochemical parameters. Additionally, we evaluated the dose-dependent effect of consumption of aronia juice containing different polyphenol doses.
MATERIALS AND METHODS

Study design and study treatments
The animals underwent a parallel, nutritional, placebo-controlled study. The animals were fed for 5-weeks with either one of the 3 protocols: 2 doses of aronia juice ("Nutrika", Belgrade, Serbia), and PLB. PLB was synthesized to contain the exact nutritional values as aronia juice, including sugars, minerals and vitamins, but without bioactive polyphenols (N. Kardum, unpublished data). The aronia juice treatment was applied in 2 polyphenol doses: full polyphenol dose (AMJ) and a dose with exactly the same chemical composition as AMJ but with 4 times less polyphenol content (¼-AMJ). All of the comparisons in the study were performed between animals receiving either of 2 polyphenol doses of aronia juice versus control animals receiving the placebo.
Characterization of the intervention treatments
Analysis of phenolic compounds in AMJ was determined using a modifi ed FolinCiocalteu method [18] . Beverage samples were diluted in distilled water to working solutions in order for absorbencies to fi t the standard calibration curve in the range of 0-600 μg/ml of gallic acid. Results were expressed as micrograms of gallic acid equivalents per ml of beverage, and data are presented as mean ± SD for 3 replicates. The polyphenol content of the study interventions is presented (Table 1) and quantities of phenolic compounds in AMJ were presented by Tomić et al. [19] . Figure  1a ). There was no statistical difference between body mass of animals between the different treatment groups on day -1 and before sacrifi ce on day 35 (P > 0.05 for both measurements, data not shown). Daily consumption of drinking solutions was estimated for each group, and their average weekly consumption in ml of solution per animal/day are presented in Figure 1b . Food consumption per cage was estimated 3 times a week and described as g of food/animal/day of every week of the experiment ( Figure 1c ). According to the determined polyphenol content, we have calculated the daily average intake of polyphenols to be 557.22 and 120.64 mg per ml of treatment for AMJ and 1/4-AMJ groups, respectively ( Figure 1d ).
Sampling and biochemical analyses
On day 35 upon treatment, all animals were sacrifi ced by cardiac puncture under anesthesia, and blood samples were collected for biochemical and laboratory analysis. Blood samples (6-8 cm 3 ) from all rats were collected by aorta abdominalis puncture in Na-citrate containing (3.8% w/v) tubes, and plasma samples were collected upon centrifugation. Liver samples were stored at -80°C. Biochemical parameters were determined from the plasma using standard laboratory kits on Cobas c-111 biochemical analyzer (Roche, Basel, Switzerland).
Preparing liver tissue for phospholipids FA analysis and lipid extraction
The liver tissue (1 g) was homogenized with a 2:1 chloroform/methanol mixture with butylated hydroxytoluene (BHT) as an antioxidant and washed with 5 times less volume of water. The resulting mixture separated into two phases, the lower phase yielding the total pure lipid extract. Further evacuation was done with 2:1 solvent systems: methanol/benzene, acetone/benzene, and ethanol/benzene. Upon adding and evacuation of chloroform and adding hexane afterwards, samples were ready for thin layer chromatography (TLC) [20] .
FA analysis in the liver tissue
The phospholipid fraction was isolated from the extracted lipids by one-dimensional TLC with the neutral lipid solvent system of petrol ether-diethyl ether-acetic acid (87:12:1, v/v) using Silica Gel GF plates (C. Merck, Darmstadt, Germany). The extraction and preparation of FA methyl esters and their gas chromatography analyses were performed as previously described [9] . Briefl y, FA methyl-ester derivatives formed from isolated plasma phospholipids fraction were separated by gas chromatography using Shimadzu GC 2014 (Shimadzu Co, Tokyo, Japan) equipped with a fl ame ionization detector and Rtx 2330 fused silica gel capillary column (60 m x 0.25 mm x 0.2 μm) (Restek Co, Bellefonte, PA, USA). The fl ame ionization detector was set at 250°C, the injection port at 220°C, and the oven temperature programmed from 130 to 190°C at heating rate of 3°C/min. Comparing sample peak retention times with authentic standards (Sigma Chemical Co, St. Louis, MO, USA) and/or the PUFA-2 standard mixture (Supelco Inc., Belleforte, PA, USA), individual FA methyl esters were identifi ed [21] .
Lipid extraction and plasma phospholipids FA analysis
The total lipid extract was prepared by the method described by Folch [21] . The phospholipid fraction was isolated as indicated. The extraction and preparation of FA methyl esters and their gas chromatography analyses were performed as indicated. The identifi cation of FA methyl esters was made by comparing sample peak retention times with authentic standards (PUFA-2 and/or 37 FAMEs mix, Supelco, Bellefonte, PA, USA) [22] . Finally, individual FA starting from palmitic acid (PA, 16:0) through docosahexaenoic acid (DHA, 22:6 n-3) were expressed as a percent in total identifi ed FA.
Statistical analysis
The results are presented as mean ± SD. The differences between the groups were calculated by one-way Analyses of Variance (One-way ANOVA) followed by Tukey's Post Test of individual signifi cant differences between the groups. Analysis was performed using the SPSS software (ver. 15.0; Chicago, IL), and the level of signifi cance was set at P < 0.05.
The sample size was calculated according to data on chokeberry effects on plasma cholesterol fractions content previously reported [23] . With statistical power set at 80% (β = 0.80) and P value of 0.05, the required number of animals was minimum 7 per group.
RESULTS
Biochemical parameters
LDL fraction was decreased in the group receiving AMJ compared to the control group receiving PLB (P = 0.021) ( Table 2) . 
The changes in plasma phospholipids FA composition upon 5-weeks placebo-controlled aronia intervention
There was a signifi cant, dose-dependent increase in plasma VA content in aroniareceiving animals in comparison with PLB-receiving animals (P = 0.039, P = 0.003, for ¼-AMJ and AMJ, respectively). A statistically signifi cant increase was observed for total plasma MUFA in animals on either AMJ or ¼-AMJ, in comparison with animals on PLB (Table 3) , which was more pronounced in the AMJ group (P = 0.017), than in ¼-AMJ (P = 0.042). Level of signifi cant difference upon ANOVA followed by Tukey's Post Hoc multiple comparison test. *P <0.05; **P <0.01.Data are presented as % of fatty acids in the total pool. SFA-total saturated fatty acids; MUFA-total monounsaturated fatty acids; PUFA-polyunsaturated fatty acids; Omega-3-Index-EPA+DHA.
Changes in liver phospholipids FA composition
The same as for plasma phospholipids, the levels of VA were signifi cantly increased in animals upon aronia juice exposure in a dose-dependent way, especially pronounced in the case of AMJ (P = 0.001), in comparison with levels of VA in control animals. Oleic acid (OA, 18:1n-9) followed the same increasing trend, which consequently led to a signifi cant increase in total MUFA levels in liver phospholipids (Table 4) , again in a dose-dependent fashion, AMJ (P = 0.023) versus PLB.
Upon polyphenol treatment there was a dose-dependent decrease in stearic acid (SA, 18:0) in liver phospholipids (P = 0.01, P = 0.005, for ¼-AMJ and AMJ, respectively) compared to PLB treatment (Table 4) .
Both aronia treatments increased the percentage of docosapentaenoic acid (DPA, 22:5n-3) (P = 0.076, P = 0.049, for AMJ and ¼-AMJ, respectively). Additionally, there was a signifi cant increase in n-3 PUFA (P = 0.053) upon AMJ treatment, compared to PLB treatment (Table 4 ).
In comparison with the control level, the level of AA, upon 5-week consumption of AMJ was signifi cantly decreased (P = 0.05) in liver phospholipids (Table 4) . Also, there was an increase in the percentage of DGLA (P = 0.05) in AMJ group compared to PLB group (Table 4) . Level of signifi cant difference upon ANOVA followed by Tukey's Post Hoc multiple comparison test. *P <0.05; **P <0.01; ***P <0.001. Data are presented as % of fatty acids in the total pool. SFA-total saturated fatty acids; MUFA-total monounsaturated fatty acids; PUFA-polyunsaturated fatty acids; Omega-3-Index-EPA+DHA.
DISCUSSION
One of the greatest advantages of the study described herein is the application of an intermediate treatment dose. Three different treatments were applied (placebo beverage, and two doses of aronia juice differing in polyphenol content) to three groups of animals, thus enabling the evaluation of a polyphenol dose-dependent effect on the lipid status. Our results indicated the favorable effect of aronia juice consumption regarding lipid classes including LDL and FA phospholipids in the plasma and liver. The novelty of this work is the investigation of a dose-dependent biological effect of polyphenol-rich aronia juice towards endogenous tissue phospholipid FA status in rats.
AMJ had a favorable decreasing effect on LDL level, while ¼-AMJ showed the opposite ( Table 2 ). The exactly same trend, but without statistical signifi cance, was observed in Glu level upon treatment with two polyphenol doses of aronia juice in comparison to the control. The hypocholesterolemic effect of aronia polyphenols was previously demonstrated in rats with experimentally induced hyperlipidemia [1, 23, 24] . The hypoglycemic effect of aronia incorporated into drinking water was observed in diabetic and normal rats upon intraperitoneal administration [25] .
The postulated protective, lipid-lowering effects of high polyphenol doses in AMJ, might account for the LDL decrease in the sub-cohort of animals receiving AMJ. Qin and Anderson [15] have reported similar results, demonstrating a benefi cial metabolic shift in fructose fed rats receiving the aronia extract in comparison with those on the fructose diet solely.
Aronia juice consumption exerted a consistent biological effect on rat plasma and liver phospholipid FA profi les, upon 5-weeks of aronia treatment. Upon treatment with both doses of aronia juice, and in comparison with the control animals receiving PLB, there was an increase in OA, VA, and total MUFA levels, both in the plasma and liver. OA has anti-atherogenic and antithrombotic properties and increases HDL to LDL ratio. Incorporation of OA into cholesterol esters, triglycerides and phospholipids of lipoprotein particles reduce lipoprotein oxidation. Incorporated into membrane lipids, OA regulates the fl uidity of the cell membrane, the effi ciency of transmembrane transport and affects signal transduction [26] .
The dose-dependent increase in VA and MUFA levels was statistically signifi cant, which indicates the additive effect of polyphenol content, in both tissues.
Studies dealing with the health implications of cis-VA status are scarce. An interesting fi nding indicates an unfavorable association of reduced levels of VA in plasma and liver of hypertensive rats with the incidence of stroke-like metabolic features [27] . The inverse association of cis-VA has been demonstrated in human studies investigating the correlation of its content in red blood cells and plasma with the incidence of myocardial infarction and heart failure with antecedent coronary heart disease, respectively [28, 29] . Accordingly, the current fi nding indicates the potentially favorable effect of aronia juice through the elevation of cis-VA plasma and liver content.
The decrease in SFA is dose/dependent in liver phospholipids, and may be indicative of AMJ protective effects because long-chain SFA are speculated to induce proinfl ammatory responses [30] and apoptosis of different vascular cell types [31] .
The herein reported decrease in SFA in both tissues additionally indicates aroniaprotective effects, especially since it is coupled with the aronia-induced statistically signifi cant increase in MUFA levels, contemplated to be associated to benefi cial infl ammatory properties [32] .
Also, DGLA that was increased in the liver upon AMJ treatment exert antiinfl ammatory properties [33] . We have reported a dose-dependent decline in AA level, in both tissues, that contributed to the dose-dependent decrease in overall n-6 PUFA. It is well known that AA is further metabolized to potent infl ammatory eicosanoids.
Additionally, both in the liver and plasma, there was an increase in EPA, DPA and DHA levels upon both polyphenol aronia doses, followed by a dose-dependent increase in total n-3 PUFA level, Omega-3-Index, as well as decrease in n-6/n-3 ratio. In contrast to n-6 PUFA, n-3 PUFA exert hypolipidemic, vasodilatory, antithrombotic, and anti-infl ammatory properties [34] .
We demonstrated an increase in Omega-3-Index (EPA + DHA content) and a decrease in AA to EPA ratio upon aronia juice consumption. Since the Omega-3-Index is inversely [35] , and AA/EPA ratio directly associated with CVD risk [36] , the results indicate additional aronia-juice cardio-protective effects.
Available exploratory preclinical research data on AM health effects [11] [12] [13] [14] support our fi ndings. Thus, consumption of aronia juice or chokeberry extract incorporated in the standard diet, has shown health-promoting properties in experimental rodent models, including rat models of arterial hypertension [13] , hyperlipidemia [1] , metabolic syndrome [14] , and glucose metabolic disorders which preferentially lead to diabetes [15] . Additionally, the pretreatment with aronia in laboratory rats has shown anti-oxidative effects in the case of diet- [12, 37] and chemically [11] induced oxidative stress. Observed benefi cial effects are attributed to the bioactivity of polyphenols. We postulated a polyphenol dose-dependent cardio-protective effect in rats, through the balancing of crucial fatty acid classes: increase in MUFA and n-3 PUFA levels, as well as an overall decline in the levels of saturated fats. Possible background of polyphenol bioactivity towards lipid metabolism is discussed in the available literature. In addition to the adipocyte cell cycle disruption, lipido-protective mechanisms for polyphenol dietary intake include several pathways: inhibition of de novo lipogenesis, lipolysis promotion, fatty acid β-oxidation promotion, as well as different anti-infl ammatory mechanisms coupled with balancing of intracellular and intra-tissue oxidative stress and insulin sensitivity improvement [38] .
We concluded a dose-dependent benefi cial effect of aronia juice consumption on LDL and plasma and liver phospholipids fatty acid profi les in aronia-treated Wistar rats. The implications from the current pre-clinical study in phospholipids FA profi les are to be confi rmed in large-scale clinical trials, encompassing both healthy and at-risk, disease-free populations.
EFEKAT ARONIJE (Aronia melanocarpa) NA MASNOKISELINSKI PROFIL FOSFOLIPIDA PLAZME I JETRE PACOVA WISTAR SOJA ZEC Manja, DEBELJAK MARTAČIĆ Jasmina, RANKOVIĆ Slavica, POKIMICA Biljana, TOMIĆ Mirko, IGNJATOVIĆ Đurđica, GLIBETIĆ Maria, POPOVIĆ Tamara Na pacovima Wistar soja je uradjena nutritivna placebo-kontrolisana studija sa ciljem da se ispitaju efekti suplementacije sokom od aronije, u trajanju od pet nedelja, na masno-kiselinski profi l fosfolipida plazme i jetre, kao i na nivoe glukoze i holesterola u plazmi. Životinje su podeljene u tri grupe od po osam životinja. Životinje su randomizirane tako da budu na jednom od tri tretmana: sok od aronije sa punom dozom polifenola (AMJ), sok od aronije sa četiri puta manjom dozom polifenola (1/4 AMJ) ili placebo (sok bez polifenola) (PLB). Svaka grupa odraslih mužjaka pacova Wistar soja je dobijala tečnost ad libitum. AMJ tretman je uticao na sniženje nivoa lipoproteina niske gustine (LDL, P<0,05) u odnosu na PLB. AMJ tretman je uticao na povećanje dihomo-γ-linolenske kiseline (DGLA, 20:3n-6, P<0,05), kao i na smanjenje nivoa arahidonske kiseline (AA, 20:4n-6, P<0,05) u odnosu na placebo u fosfolipidima jetre. Tretman sokom od aronije sa visokom dozom polifenola je značajno povećao mononezasićene masne kiseline (MUFA), kako u fosfolipidima jetre (P<0,05), tako i u fosfolipidima plazme (P<0,05). Obe doze soka od aronije su značajno povećale nivo korisnih n-3 polinezasićenih masnih kiselina (PUFA) u plazmi i jetri. Uočeno je i dozno zavisno značajno povećanje cis-vakcenske kiseline (VA, 18:1n-7, P<0,001) u fosfolipidima plazme i jetre. Naši rezultati ukazuju na korisne efekte soka od aronije na lipidne parametre kod pacova Wistar soja. Ovakvi nalazi sugerišu mogućnost da unos soka od aronije može biti od koristi u strategijama primarne prevencije kardiovaskulanih oboljenja u humanoj populaciji.
